Advances in tethered photopharmacology for precise optical control of signaling proteins DOI Creative Commons
Johannes Broichhagen, Joshua Levitz

Current Opinion in Pharmacology, Год журнала: 2022, Номер 63, С. 102196 - 102196

Опубликована: Март 2, 2022

Язык: Английский

Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function DOI

Amr Ellaithy,

Javier González‐Maeso,

Diomedes A. Logothetis

и другие.

Trends in Biochemical Sciences, Год журнала: 2020, Номер 45(12), С. 1049 - 1064

Опубликована: Авг. 26, 2020

Язык: Английский

Процитировано

82

A fine-tuned azobenzene for enhanced photopharmacology in vivo DOI Creative Commons
Vanessa A. Gutzeit, Amanda Acosta-Ruiz, Hermany Munguba

и другие.

Cell chemical biology, Год журнала: 2021, Номер 28(11), С. 1648 - 1663.e16

Опубликована: Март 19, 2021

Язык: Английский

Процитировано

57

In vivo photopharmacology with a caged mu opioid receptor agonist drives rapid changes in behavior DOI
Xiang Ma, Desiree A. Johnson, Xinyi Jenny He

и другие.

Nature Methods, Год журнала: 2023, Номер 20(5), С. 682 - 685

Опубликована: Март 27, 2023

Язык: Английский

Процитировано

25

In vivo photopharmacology with light-activated opioid drugs DOI Creative Commons
Shannan P. McClain, Xiang Ma, Desiree A. Johnson

и другие.

Neuron, Год журнала: 2023, Номер 111(24), С. 3926 - 3940.e10

Опубликована: Окт. 16, 2023

Traditional methods for site-specific drug delivery in the brain are slow, invasive, and difficult to interface with recordings of neural activity. Here, we demonstrate feasibility experimental advantages vivo photopharmacology using "caged" opioid drugs that activated light after systemic administration an inactive form. To enable bidirectional manipulations endogenous receptors vivo, developed photoactivatable oxymorphone (PhOX) naloxone (PhNX), variants mu receptor agonist antagonist naloxone. Photoactivation PhOX multiple areas produced local changes occupancy, metabolic activity, neuronal calcium neurochemical signaling, pain- reward-related behaviors. Combining photoactivation optical recording extracellular dopamine revealed adaptations sensitivity mesolimbic circuitry response chronic morphine administration. This work establishes a general framework study basis action.

Язык: Английский

Процитировано

23

Optogenetics with Atomic Precision─A Comprehensive Review of Optical Control of Protein Function through Genetic Code Expansion DOI Creative Commons
Maura E. Charette,

Carolyn Rosenblum,

Olivia Shade

и другие.

Chemical Reviews, Год журнала: 2025, Номер unknown

Опубликована: Фев. 10, 2025

Conditional control of protein activity is important in order to elucidate the particular functions and interactions proteins, their regulators, substrates, as well impact on behavior a cell or organism. Optical provides perhaps optimal means introducing spatiotemporal over function it allows for tunable, rapid, noninvasive activation its native environment. One method optical through introduction photocaged photoswitchable noncanonical amino acids (ncAAs) genetic code expansion cells animals. Genetic incorporation photoactive ncAAs at key residues tool activation, sometimes deactivation, activity. Importantly, site can typically be rationally selected based structural, mechanistic, computational information. In this review, we comprehensively summarize applications lysine, tyrosine, cysteine, serine, histidine, glutamate, aspartate derivatives, phenylalanine analogues. The extensive diverse list proteins that have been placed under demonstrates broad applicability methodology.

Язык: Английский

Процитировано

1

International Union of Basic and Clinical Pharmacology. CXI. Pharmacology, Signaling, and Physiology of Metabotropic Glutamate Receptors DOI Open Access
Karen J. Gregory, Cyril Goudet

Pharmacological Reviews, Год журнала: 2020, Номер 73(1), С. 521 - 569

Опубликована: Дек. 23, 2020

Metabotropic glutamate (mGlu) receptors respond to glutamate, the major excitatory neurotransmitter in mammalian brain, mediating a modulatory role that is critical for higher-order brain functions such as learning and memory. Since first mGlu receptor was cloned 1992, eight subtypes have been identified along with many isoforms splice variants. The are transmembrane-spanning proteins belonging class C G protein–coupled family represent attractive targets multitude of central nervous system disorders. Concerted drug discovery efforts over past three decades yielded wealth pharmacological tools including subtype-selective agents competitively block or mimic actions act allosterically via distinct sites enhance inhibit activity. Herein, we review physiologic pathophysiological roles individual pleiotropic nature intracellular signal transduction arising from each. We provide comprehensive analysis vitro vivo properties prototypical commercially available orthosteric agonists antagonists well allosteric modulators, ligands entered clinical trials. Finally, highlight emerging areas research hold promise facilitate rational design highly selective receptor-targeting therapeutics future.

Significance Statement

metabotropic therapeutic range psychiatric neurological Over decades, intense diverse acting either allosterically, which enabled dissection fundamental biological process modulated by established proof concept indications. molecular pharmacology offering new avenues selectively modulate neurotransmission.

Язык: Английский

Процитировано

52

Photoswitchable Pseudoirreversible Butyrylcholinesterase Inhibitors Allow Optical Control of Inhibition in Vitro and Enable Restoration of Cognition in an Alzheimer’s Disease Mouse Model upon Irradiation DOI
Matthias Scheiner, Alexandra Sink, Matthias Hoffmann

и другие.

Journal of the American Chemical Society, Год журнала: 2022, Номер 144(7), С. 3279 - 3284

Опубликована: Фев. 9, 2022

To develop tools to investigate the biological functions of butyrylcholinesterase (BChE) and mechanisms by which BChE affects Alzheimer's disease (AD), we synthesized several selective, nanomolar active, pseudoirreversible photoswitchable inhibitors. The compounds were able specifically influence different kinetic parameters inhibition process light. For one compound, a 10-fold difference in IC50-values (44.6 nM cis, 424 trans) vitro was translated an "all or nothing" response with complete recovery murine cognition-deficit AD model at dosages as low 0.3 mg/kg.

Язык: Английский

Процитировано

35

Photoswitchable Serotonins for Optical Control of the 5‐HT2A Receptor** DOI
Johannes Morstein, Giovanna Romano, Belinda E. Hetzler

и другие.

Angewandte Chemie International Edition, Год журнала: 2022, Номер 61(18)

Опубликована: Янв. 6, 2022

Serotonin receptors play central roles in neuromodulation and are critical drug targets for psychiatric disorders. Optical control of serotonin receptor subtypes has the potential to greatly enhance our understanding spatiotemporal dynamics function. While other neuromodulatory have been successfully rendered photoswitchable, reversible photocontrol not achieved, representing a major gap GPCR photopharmacology. Herein, we develop first tools that allow such control. Azo5HT-2 shows light-dependent 5-HT2A R agonism, with greater activity cis-form. Based on docking test compound analysis, also photoswitchable orthogonal, remotely-tethered ligands (PORTLs). These BG-Azo5HTs provide rapid, reversible, repeatable optical following conjugation SNAP-tagged R. Overall, this study provides foundation broad extension photopharmacology family.

Язык: Английский

Процитировано

33

N-Methyl deuterated rhodamines for protein labelling in sensitive fluorescence microscopy DOI Creative Commons
Kilian Roßmann, Kerem Can Akkaya, Pascal Poc

и другие.

Chemical Science, Год журнала: 2022, Номер 13(29), С. 8605 - 8617

Опубликована: Янв. 1, 2022

Rhodamine fluorophores are setting benchmarks in fluorescence microscopy. Herein, we report the deuterium (d12) congeners of tetramethyl(silicon)rhodamine, obtained by isotopic labelling four methyl groups, show improved photophysical parameters (

Язык: Английский

Процитировано

29

The therapeutic potential of metabotropic glutamate receptor modulation for schizophrenia DOI
Branden J. Stansley, P. Jeffrey Conn

Current Opinion in Pharmacology, Год журнала: 2018, Номер 38, С. 31 - 36

Опубликована: Фев. 1, 2018

Язык: Английский

Процитировано

55